Immucell (ICCC) EBT (QoQ) (2010 - 2025)
Immucell (ICCC) EBT (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Immucell | 91.37 Mn | 82.51 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,003.48% |
| Sep 30, 2025 | -126.86% |
| Jun 30, 2025 | -65.23% |
| Mar 31, 2025 | 178.32% |
| Dec 31, 2024 | 174.33% |
| Sep 30, 2024 | 54.23% |
| Jun 30, 2024 | -250.56% |
| Mar 31, 2024 | 61.66% |
| Dec 31, 2023 | -21.14% |
| Sep 30, 2023 | 31.81% |
| Jun 30, 2023 | 40.43% |
| Mar 31, 2023 | -38.84% |
| Dec 31, 2022 | -155.89% |
| Sep 30, 2022 | 4.65% |
| Jun 30, 2022 | -232.77% |
| Mar 31, 2022 | 583.58% |
| Dec 31, 2021 | -51.70% |
| Sep 30, 2021 | 10.41% |
| Jun 30, 2021 | 131.98% |
| Mar 31, 2021 | -328.27% |